Intraocular surgery under adalimumab therapy in patients with refractory uveitis: a single center study of 23 eyes

ConclusionSurgery for refractory uveitis under ADA treatment is safe and achieves good visual outcome and uveitis control if inflammation exists before surgery. ADA does not increase the risk of infections. Intraoperative findings of UME at surgery requires attention for postoperative relapse.
Source: Japanese Journal of Ophthalmology - Category: Opthalmology Source Type: research